Since the early 1990s, New Zealand companies, particularly those associated with safety sensitive industry sectors, have been developing Workplace Alcohol and Other Drug Policies and Procedures which include testing.
The Health and Safety at Work Act 2015 has now put more responsibilities on employers and managers to identify the risk of potential hazards, manage these risks and eliminate them. A person at work under the influence of alcohol and/ or drugs has always been identified as a potential risk.
In 2020 medicinal cannabis has been legalised and the range of novel psychoactive substances (NPS) has increased. On 17 October 2020, the results of the referendum for legalising of cannabis for personal use will be revealed.
This seminar will cover:
- Impact of medicinal cannabis on Company Policies
- Impact of legalisation of cannabis on Company Policies (dependant on referendum)
- Importance of testing to cover the NPSs and misused medications (lab based testing)
- Role of Medical Review Officer (MRO)
- Requirement for collecting agents to have knowledge of their clients’ policies
- Quality Drug Testing & mandatory requirements to conduct Quality Controls, Proficiency testing and Confirmations
- Updated AS/NZS 4308: 2021 insight
- Current status of Oral Fluid testing
Do you have any questions you would like to submit to Sue in advance? See the registration form to send yours when you register.
Please note that this session will not be recorded and the presentation will not be shared post event.
Lunchtime Seminars - Key Information
- Lunchtime Seminar charges are $10 for all RiskNZ members, and $15 for non-members. You can pay directly via credit card online, or an invoice will be sent to you following registration.
- Seminars commences at 12:00pm and will finish at 1:00pm.
- Webinar information for logging in and participating in the webinar will be shared with registered participants at least one day before the seminar.
